Most takeda pharmaceuticals related news are at:
Takeda and Zinfandel Pharmaceuticals Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimer’... 26 Aug 2013 | 10:00 am
Osaka, Japan, August 27, 2013 and Durham, NC, August, 26, 2013 – Takeda Pharmaceutical Company Limited (“Takeda”) and its partner, Zinfandel Pharmaceuticals, Inc. (“Zinfandel”), today announced the in...
Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcer... 21 Aug 2013 | 10:00 am
Osaka, Japan – August 21, 2013 – Takeda Pharmaceutical Company Limited (“Takeda”) today announced that results from two Phase 3 studies evaluating vedolizumab, an investigational humanized monoclonal ...
More takeda pharmaceuticals related news:
New Study Shows Dangerous Actos Side Effects floridaconsumerlawyerblog.com 14 Aug 2012 | 02:50 am
Actos is a drug usually prescribed to patients with diabetes to aid in their insulin uptake. However, many ill patients have filed lawsuits against Takeda Pharmaceuticals, the drug’s manufacturer, due...
An Appeal To Remember federalmdlawyers.wordpress.com 19 Jan 2013 | 02:38 am
In US ex rel. Noah Nathan v. Takeda Pharmaceuticals, Relator, a sales manager for Takeda, brought a qui tam action against his employer under the False Claims Act, 31 U.S.C. 3729-3733, alleging that ...
NPS Pharmaceuticals and Takeda Revise Agreements and NPS Re-Gains Full Worldwide Rights to Teduglutide and Recombinant Human Parathyroid Hormone 1-84 nycomed.com 19 Mar 2013 | 01:33 pm
BEDMINSTER, New Jersey and Osaka, Japan – March 19, 2013 – NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) and Takeda Pharmaceutical Company Limited (TSE: 4502, “Takeda”) announced today that NPS has re-gain...
Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohn's Disease in the Euro... nycomed.com 7 Mar 2013 | 11:00 am
Osaka, Japan – March 7, 2013 – Takeda Pharmaceutical Company Limited (“Takeda”) today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EM...
Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazo... nycomed.com 26 Jan 2013 | 11:00 am
Deerfield, Ill., January 25, 2013, and Osaka, Japan, January 26, 2013 – Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announ...
Takeda Establishes New Trading Company and Reinforces Business Structure in China nycomed.com 22 Jan 2013 | 11:00 am
Osaka, Japan, January 22, 2013 – Takeda Pharmaceutical Company Limited (“Takeda”) today announced the launch of a new trading company in China, Takeda (China) International Trading Co., Ltd. (“TCIT”),...
Takeda to Sell Non-Colcrys URL Pharma, Inc. Generic Business to Sun Pharmaceutical nycomed.com 18 Dec 2012 | 11:00 am
Deerfield, Ill., Dec. 17, 2012 and Osaka, Japan, Dec. 18, 2012 – Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda’s wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., In...
Takeda and Millennium Announce European Conditional Marketing Authorisation for ADCETRIS® (Brentuximab Vedotin) nycomed.com 31 Oct 2012 | 10:00 am
Osaka, Japan, and Cambridge, Mass., October 31, 2012 – Takeda Pharmaceutical Company Limited (TSE:4502, “Takeda”) and Millennium: The Takeda Oncology Company, today announced that the European Commiss...
Takeda Launches New Subsidiary in Ecuador nycomed.com 21 Mar 2013 | 01:20 pm
Demonstrates Takeda’s long-term commitment to the Latin American market Zurich, Switzerland, March 21, 2013 --- Takeda Pharmaceuticals International GmbH (“Takeda”), today announced further expansion ...
New Study Shows Dangerous Actos Side Effects floridaconsumerlawyerblog.com 13 Aug 2012 | 11:50 pm
Actos is a drug usually prescribed to patients with diabetes to aid in their insulin uptake. However, many ill patients have filed lawsuits against Takeda Pharmaceuticals, the drug’s manufacturer, due...
